FDA Approved: VELPHORO — Original Application (Fresenius Medical Care Renal Therapies Group, LLC)

View source ↗

Summary

FDA approved Velphoro (sucroferric oxyhydroxide) under an original NDA for the treatment of hyperphosphatemia in adults with chronic kidney disease on dialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Drugs mentioned

• VELPHORO (sucroferric oxyhydroxide)

Snippet

ORIG AP for VELPHORO (SUCROFERRIC OXYHYDROXIDE)